Greater Combined Reductions in HBA1C ≥1.0% and Weight ≥5.0% With Semaglutide vs. Comparators in Type-2 Diabetes
Helena W. Rodbard, Srikanth Bellary, Irene Hramiak, Yutaka Seino, Robert Silver, Lars Holm Damgaard, Gurudutt Nayak, Jeppe Zacho, and Vanita R. Aroda
Endocrine Practice
In-Press
ABSTRACT
PDF
